These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 4099868)
1. Histochemical findings of fibrinolytic activities in the prostatic gland. Sugiura H; Shimaya M Invest Urol; 1970 Sep; 8(2):188-94. PubMed ID: 4099868 [No Abstract] [Full Text] [Related]
2. [Changes in the collagen and elastic fibers during processes of involution of the prostate gland]. Pelova N Arkh Patol; 1969; 31(5):61-5. PubMed ID: 4245931 [No Abstract] [Full Text] [Related]
3. A novel approach to the characterization of whole prostate pathology in glycol methacrylate. Monger LE; Nagabhushan M; Pretlow TG; Pretlow TP Am J Pathol; 1994 Jul; 145(1):54-60. PubMed ID: 8030756 [TBL] [Abstract][Full Text] [Related]
4. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer]. Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673 [TBL] [Abstract][Full Text] [Related]
5. [Histochemical studies on the content of plasmin in the normal and hyperplastic prostate (author's transl)]. Dunzendorfer U; Weber W Acta Histochem; 1977; 58(2):332-6. PubMed ID: 70942 [TBL] [Abstract][Full Text] [Related]
6. [Pathological findings of the prostate and their consequences: a critical view]. Dhom G Verh Dtsch Ges Pathol; 1993; 77():70-2. PubMed ID: 7511305 [No Abstract] [Full Text] [Related]
7. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588 [TBL] [Abstract][Full Text] [Related]
8. [Histochemical characteristics of the prostate gland under normal conditions, in nodular hyperplasia and cancer]. Bialik VV Arkh Patol; 1973; 35(12):12-8. PubMed ID: 4130950 [No Abstract] [Full Text] [Related]
9. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Festuccia C; Vincentini C; di Pasquale AB; Aceto G; Zazzeroni F; Miano L; Bologna M Oncol Res; 1995; 7(3-4):131-8. PubMed ID: 8555646 [TBL] [Abstract][Full Text] [Related]
10. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor]. Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739 [TBL] [Abstract][Full Text] [Related]
11. The effects of various manipulations on serum phosphatase levels in benign disease. Greene FT; Thompson IM J Urol; 1974 Aug; 112(2):232-6. PubMed ID: 4135604 [No Abstract] [Full Text] [Related]
12. Alterations in serum lactate dehydrogenase activity and its isoenzyme pattern after massage of the prostate. Value in differentiating carcinoma from benign hyperplasia of the prostate. Ishibe T Invest Urol; 1971 Sep; 9(2):104-8. PubMed ID: 5120368 [No Abstract] [Full Text] [Related]
13. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia]. Zang T; Sun F; Li Y Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the histochemical method for studying the fibrinolytic activities of tissue sections. Rejniak L; Prokopowicz J; Niewiarowski S; Worowski K Folia Histochem Cytochem (Krakow); 1966; 4(3):325-31. PubMed ID: 5919083 [No Abstract] [Full Text] [Related]
17. Lactic dehydrogenase isozymes in benign and malignant prostatic tissues. Srinivasan V; Keil E; Villalba R; Baron T; Clark SS Invest Urol; 1973 Nov; 11(3):244-7. PubMed ID: 4127178 [No Abstract] [Full Text] [Related]
18. Ultracytochemical and biochemical study of acid and alkaline phosphatases in human prostatic cancer cell. Aso Y; Yokoyama M; Okada K; Tokue A; Koiso K Invest Urol; 1972 Jan; 9(4):329-34. PubMed ID: 4110265 [No Abstract] [Full Text] [Related]
19. Steroids and the prostate. Peeling WB; Griffiths K Proc R Soc Med; 1972 Feb; 65(2):127-8. PubMed ID: 5085013 [No Abstract] [Full Text] [Related]
20. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma. Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]